메뉴 건너뛰기




Volumn 15, Issue 2, 2007, Pages 38-45

Smoking cessation in the elderly

(2)  Elhassan, Amir a   Chow, R Dobbin a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ELDERLY CARE; GERIATRIC CARE; HUMAN; INTERVENTION STUDY; PATIENT COUNSELING; REVIEW; SMOKING; SMOKING CESSATION;

EID: 33847182756     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (3)

References (21)
  • 1
    • 33747141495 scopus 로고    scopus 로고
    • Efficacy of smoking cessation intervention among special populations: Review of the literature from 2000 to 2005
    • Doolan DM, Froelicher ES. Efficacy of smoking cessation intervention among special populations: Review of the literature from 2000 to 2005. Nurs Res 2006;55(4 suppl 1):S29-S37.
    • (2006) Nurs Res , vol.55 , Issue.4 SUPPL. 1
    • Doolan, D.M.1    Froelicher, E.S.2
  • 2
    • 0037291542 scopus 로고    scopus 로고
    • Smoking cessation in the elderly
    • Appel DW, Aldrich TK. Smoking cessation in the elderly. Clin Geriatr Med 2003;19(1):77-100.
    • (2003) Clin Geriatr Med , vol.19 , Issue.1 , pp. 77-100
    • Appel, D.W.1    Aldrich, T.K.2
  • 3
    • 0033864348 scopus 로고    scopus 로고
    • Cigarette smoking among the elderly: Disease consequences and me benefits of cessation
    • Burns DM. Cigarette smoking among the elderly: Disease consequences and me benefits of cessation. Am J Health Promot 2000; 14(6):357-361.
    • (2000) Am J Health Promot , vol.14 , Issue.6 , pp. 357-361
    • Burns, D.M.1
  • 4
    • 33645636849 scopus 로고    scopus 로고
    • Smoking and deaths between 40 and 70 years of age in women and men
    • Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 2006;144(6):381-389.
    • (2006) Ann Intern Med , vol.144 , Issue.6 , pp. 381-389
    • Vollset, S.E.1    Tverdal, A.2    Gjessing, H.K.3
  • 5
    • 0030000037 scopus 로고    scopus 로고
    • Reaching midlife and older smokers: Tailored interventions for routine medical care
    • Morgan GD, Noll EL, Orleans CT, et al. Reaching midlife and older smokers: Tailored interventions for routine medical care. Prev Med 1996;25(3):346-354.
    • (1996) Prev Med , vol.25 , Issue.3 , pp. 346-354
    • Morgan, G.D.1    Noll, E.L.2    Orleans, C.T.3
  • 6
    • 0003649181 scopus 로고
    • The Health Benefits of Smoking Cessation
    • U.S. Department of Health and Human Services, DHHS, Washington, DC: U.S. Government Printing Office;, Publication No (CDC) 90:8416. Available at:, Accessed January 4
    • U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General (DHHS). Washington, DC: U.S. Government Printing Office; 1990: Publication No (CDC) 90:8416. Available at: www.cdc.gov/tobacco/sgr/index.htm. Accessed January 4, 2007.
    • (1990) A Report of the Surgeon General
  • 9
    • 1642538353 scopus 로고    scopus 로고
    • Inpatient smoking-cessation counseling and all-cause mortality among the elderly
    • Brown D, Croft J, Schenck AP, et al. Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am J Prev Med 2004;26(2):112-118.
    • (2004) Am J Prev Med , vol.26 , Issue.2 , pp. 112-118
    • Brown, D.1    Croft, J.2    Schenck, A.P.3
  • 12
    • 0035143861 scopus 로고    scopus 로고
    • Individual differences in preferences for and responses to four nicotine replacement products
    • West R, Hajek P, Nilsson F, et al. Individual differences in preferences for and responses to four nicotine replacement products. Psychapharmacology (Berl) 2001;153(2):225-230.
    • (2001) Psychapharmacology (Berl) , vol.153 , Issue.2 , pp. 225-230
    • West, R.1    Hajek, P.2    Nilsson, F.3
  • 13
    • 8544260343 scopus 로고    scopus 로고
    • Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of bupropion SR
    • Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of bupropion SR. Addiction 2004;99:1462-1469.
    • (2004) Addiction , vol.99 , pp. 1462-1469
    • Scharf, D.1    Shiffman, S.2
  • 14
    • 0034929062 scopus 로고    scopus 로고
    • Bupropion for smoking cessation: Predictors of successful outcome
    • Dale LC, Glover ED, Sachs DP, et al. Bupropion for smoking cessation: Predictors of successful outcome. Chest 2001;119:1357-1364.
    • (2001) Chest , vol.119 , pp. 1357-1364
    • Dale, L.C.1    Glover, E.D.2    Sachs, D.P.3
  • 15
    • 0032066120 scopus 로고    scopus 로고
    • Treatment of depression in elderly patients: Recent advances
    • DasGupta K. Treatment of depression in elderly patients: Recent advances. Arch Fam Med 1998;7(3):274-280.
    • (1998) Arch Fam Med , vol.7 , Issue.3 , pp. 274-280
    • DasGupta, K.1
  • 16
    • 0032511735 scopus 로고    scopus 로고
    • A randomized trial of nortriptyline for smoking cessation
    • Prochazka AV, Weaver MJ, Keller RT, et al. A randomized trial of nortriptyline for smoking cessation. Arch Intern Med 1998;158 (18):2035-2039.
    • (1998) Arch Intern Med , vol.158 , Issue.18 , pp. 2035-2039
    • Prochazka, A.V.1    Weaver, M.J.2    Keller, R.T.3
  • 17
    • 7544250480 scopus 로고    scopus 로고
    • A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation
    • Prochazka AV, Kick S, Steinbrunn C, et al. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. Arch Intern Med 2004;164:2229-2233.
    • (2004) Arch Intern Med , vol.164 , pp. 2229-2233
    • Prochazka, A.V.1    Kick, S.2    Steinbrunn, C.3
  • 18
    • 33646481040 scopus 로고    scopus 로고
    • Gelfand EV, Cannon CP. Rimonabant: A cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors. J Am Coll Cardiol 2006;47(10):1919-1926. Epub 2006 Apr 24.
    • Gelfand EV, Cannon CP. Rimonabant: A cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors. J Am Coll Cardiol 2006;47(10):1919-1926. Epub 2006 Apr 24.
  • 19
    • 33745599140 scopus 로고    scopus 로고
    • the Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial
    • Tonstad S, Tonnesen P, Hajek P, et al; the Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial. JAMA 2006;296:64-71.
    • (2006) JAMA , vol.296 , pp. 64-71
    • Tonstad, S.1    Tonnesen, P.2    Hajek, P.3
  • 20
    • 33745611449 scopus 로고    scopus 로고
    • the Varenicline Phase 3 Study Group. Efficacy or varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial
    • Jorenby DE, Hays JT, Rigotti NA, et al; the Varenicline Phase 3 Study Group. Efficacy or varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA 2006;296:56-63.
    • (2006) JAMA , vol.296 , pp. 56-63
    • Jorenby, D.E.1    Hays, J.T.2    Rigotti, N.A.3
  • 21
    • 33745614361 scopus 로고    scopus 로고
    • the Varenicline Phase 3 Study Group. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial
    • Gonzales D, Rennard SI, Nides M, et al, the Varenicline Phase 3 Study Group. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA 2006; 296:47-55.
    • (2006) JAMA , vol.296 , pp. 47-55
    • Gonzales, D.1    Rennard, S.I.2    Nides, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.